4//SEC Filing
White Lauren 4
Accession 0001209191-22-032509
CIK 0001662579other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:15 PM ET
Size
7.2 KB
Accession
0001209191-22-032509
Insider Transaction Report
Form 4
White Lauren
Chief Financial Officer
Transactions
- Exercise/Conversion
Performance Restricted Stock Units
2022-05-25−3,750→ 22,500 totalExp: 2025-02-28→ Common Stock (3,750 underlying) - Exercise/Conversion
Common Stock
2022-05-25+3,750→ 3,750 total
Footnotes (1)
- [F1]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001864430
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:15 PM ET
- Size
- 7.2 KB